Blog
RSS FeedPosted by Michael Wonder on 08 Oct 2020
CSL confirms UQ vaccine production, trials set for December
8 October 2020 - CSL says it is talking with partner organisations to help roll out doses of the University ...
Posted by Michael Wonder on 08 Oct 2020
Vaccine suppliers given indemnity for 'inevitable' side effects
8 October 2020 - The Morrison government has given the suppliers of two COVID-19 vaccines indemnity against prosecution for rare ...
Posted by Michael Wonder on 08 Oct 2020
Australian Government finalises University of Queensland-CSL COVID-19 vaccine agreement
8 October 2020 - The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to ...
Posted by Michael Wonder on 06 Oct 2020
PixCell Medical announces regulatory approval from Australian TGA for HemoScreen point of care hematology analyser
5 October 2020 - PixCell Medical announced today that it has received regulatory approval from the Australian TGA for the ...
Posted by Michael Wonder on 28 Sep 2020
Maritime union rejects claims medical supplies and food are being held up in pay dispute
29 September 2020 - There are fears container ships stuck off the Sydney coast could result in major delays to ...
Posted by Michael Wonder on 27 Sep 2020
Medicine shortage fears amid MUA pay dispute
28 September 2020 - Critical medicines are blocked from entering Australia as the supply chain becomes collateral damage in a wharfie ...
Posted by Michael Wonder on 24 Sep 2020
'Pharma resistance’ to battle superbugs
24 September 2020 - A group of pharmaceutical giants, biotech companies, industry peak bodies and the CSIRO have banded together ...
Posted by Michael Wonder on 24 Sep 2020
GW Pharmaceuticals receives Australian Therapeutic Goods Administration approval for Epidyolex (cannabidiol) for the treatment of seizures in patients with two rare, severe forms of childhood-onset epilepsy
23 September 2020 - This represents the third successful regulatory approval globally for GW’s plant-derived cannabis-based medicine. ...
Posted by Michael Wonder on 23 Sep 2020
Australia now eligible to purchase COVID-19 vaccine doses through COVAX
23 September 2020 - The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they ...
Posted by Michael Wonder on 22 Sep 2020
Australia commits $123 million to a worldwide vaccine distribution alliance
22 September 2020 - Australia has committed $123 million to a worldwide vaccine distribution alliance, opening up the opportunity to ...
Posted by Michael Wonder on 22 Sep 2020
New early scientific advice service to support medicine registrations
22 September 2020 - The Therapeutic Goods Administration has launched a new initiative - the Early Scientific Advice service - ...
Posted by Michael Wonder on 20 Sep 2020
Almost $6 million poured into three Australian made COVID-19 vaccines
20 September 2020 - The Federal Government will invest almost $6 million to support the development of three Australia made ...
Posted by Michael Wonder on 14 Sep 2020
Revolutionary cancer medicine Vitrakvi shrinks tumours in days
14 September 2020 - Doctors are amazed by a new cancer medicine offering Australian kids a new lease on life, but ...
Posted by Michael Wonder on 09 Sep 2020
TGA approves yet another flu vaccine
9 September 2020 - As its brand name suggests, Flucelvax Quad is a new quadrivalent influenza vaccine. ...
Posted by Michael Wonder on 09 Sep 2020
COVID-19 vaccine development
9 September 2020 - Australia’s COVID-19 Vaccine and Treatment Strategy supports early access to, and delivery of, safe and effective COVID-19 ...